Swiss Consult On Local IVDR Until July, EU MRA Awaited Still
With the days remaining before the EU MDR is mandatory down into the single figures, Swiss medtechs are still out in the cold
Executive Summary
A medtech MRA with the EU remains outstanding. Meanwhile Swiss medtech regulations continue to be harmonized with those of the EU in readiness for future mutual recognition.
You may also be interested in...
Swiss Break Off High Level EU Talks But Say Medtech MRA Should Be Updated
26 May was a big day for the EU with the MDR coming into effect, and an even bigger one for Switzerland as it ended its institutional agreement talks with the EU – but the medtech MRA might be spared.
Swiss Medtechs Demand Renewed Negotiation Efforts As Latest EU Talks Falter
Top level EU talks on continued Swiss access to the EU single market have yet to succeed, but with EU MDR implementation in just a month, the stakes for Swiss medtechs are high.
The Sustainability Stakes Are Rising: ‘We Cannot Recycle Our Way Out Of This’
The journey to Net Zero, described as ‘the defining issue of our time,’ will get harder in the coming decade. Failure to keep up the pressure will result in more long-term health conditions, increasing deaths and higher costs. The UK NHS is a Net Zero exemplar globally, but without a systemic approach, its compliance efforts could stutter.